Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2)

Leukemia

Volumn 11, Issue 2, 1997, Pages 284-293

  Van Riet, I ^a   De Greef, C ^a   Aharchi, F ^a   Woischwill, C ^a   De Waele, M ^a   Bakkus, M ^a   Lacor, P ^a   Schots, R ^a   Van Camp, B ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Apoptosis; Bone marrow stroma; Cell line; IL 6; Multiple myeloma

Indexed keywords

CD38 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; ONCOSTATIN M;

ADULT; APOPTOSIS; ARTICLE; BONE MARROW; CANCER CELL CULTURE; CASE REPORT; CELL PROLIFERATION; CELL STRUCTURE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL; STROMA;

EID: 16944364509     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400564     Document Type: Article

References (11)

1. Zhang XG, Klein B, Bataille R. lnterleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 11-13.
2. Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R. lnterleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma, fur Cytokine Net 1990; 1: 193-201.
3. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517-526.
4. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B. Ciliary neurotropic factor, interleukin-11, leukemia inhibitory factor and oncostatin M are growth factors for human myeloma cell lines using the interleukin-6 signal transducer gp130. J Exp Med 1994; 177: 1337-1342.
5. Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu ZJ, Morel-Fournier B, Harousseau JL, Bataille R, Rossi JF, Klein B. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 1995; 83: 2521-2527.
6. Lemoli RM, Fortuna A, Grande A, Gamberi B, Bonsi L, Fogli M, Amabile M, Cavo M, Ferrari S, Tura S. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells. Br J Haematol 1994; 88: 760-769.
7. Klein B. Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma. Semin Hematol 1995; 32: 4-19.
8. Lu ZY, Zhang XG, Gu ZJ, Yasukawa K, Amiot M, Etrillard M, Bataille R, Klein B. A highly sensitive quantitative bioassay for human interleukin-11. J Immunol Meth 1994; 173: 19-26.
9. Pellat-Deceunynck C, Amiot M, Bataille R, Van Riet I, Van Camp B, Omede P, Boccadoro M. Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after. Blood 1995; 86: 4001-4002.
10. Eton O, Scheinberg A, Houghton N. Establishment and characterization of two myeloma cell lines secreting kappa light chains. Leukemia 1989; 3: 729-735.
11. Hata H, Matsuzaki H, Sonoki T, Takemoto S, Kuribayashi N, Takatsuki K. Establishment of a CD45-positive immature plasma cell line from an aggressive multiple myeloma with high serum lactate dehydrogenase. Leukemia 1994; 8: 1768-1773.